State Street SSGA美國股票溢價盈餘主動型ETF SPIN 深 滬
等待開盤 05-16 09:30:00 美东时间
32.07
-0.200
-0.62%
華盛通- 最 高32.11
- 今 開32.07
- 成交量 1380股
- 最 低 32.035
- 昨 收 32.27
- 總市值 4618.08万
- 52周最高 32.4194
- 市盈率 靜 --
- 換手率 0.10%
- 52周最低 26.6782
- 委 比 99.60%
- 總股本 144.00万
- 歷史最高 32.4194
- 量 比 0.21
- 振 幅 0.23%
- 歷史最低 22.7113
- 每 手 1
- 風險率 1.58%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Xtant Medical Hldgs Q1 2026 Earnings Call Transcript
Xtant Medical Hldgs (AMEX:XTNT) released first-quarter financial results and ho...
05-13 21:50
Vistagen Announces Its Data From PALISADE-3 Phase 3 Trial Of Fasedienol Demonstrates Well-Toleration, No Drug-Related Safety Concerns
Vistagen (NASDAQ:VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product candidates called pherines,
05-12 19:34
Flex Q4 2026 Earnings Call: Complete Transcript
Flex (NASDAQ:FLEX) held its fourth-quarter earnings conference call on Wednesda...
05-06 21:29
BRIEF-OpenAI's Altman Discussed Spinning Out Co's Robotics, Consumer Hardware Divisions Late Last Year - WSJ
BRIEF-OpenAI's Altman Discussed Spinning Out Co's Robotics, Consumer Hardware Divisions Late Last Year - WSJ May 4 (Reuters) - OPENAI CHIEF EXECUTIVE SAM ALTMAN DISCUSSED SPINNING OUT THE COMPANY'S ROBOTICS AND CONSUMER HARDWARE DIVISIONS LATE LAST YEAR - WSJ PLAN TO SPIN OUT OPENAI'S ROBOTICS, CONS
05-05 09:04
AtaiBeckley Announces Expanded Phase 2a Results For EMP-01 In Adults With Social Anxiety Disorder That Demonstrate Clinically Meaningful And Consistent Improvements Across Clinician-Rated Symptoms, Patient-Reported Experience And Real-World Behavioral Outcomes
At Day 43, EMP‑01 achieved a 38% reduction vs 15% on placebo (Hedges' g=0.84) on the patient-reported Social Phobia Inventory (SPIN), a 32% reduction vs 14% on placebo on the Subtle Avoidance Frequency Examination
04-22 18:11
BRIEF-Warner Music Central Europe And Spinnin’ Records Launches Spinnin’ Records Germany
BRIEF-Warner Music Central Europe And Spinnin’ Records Launches Spinnin’ Records Germany April 10 (Reuters) - Warner Music Group Corp WMG.O : WARNER MUSIC GROUP: WARNER MUSIC CENTRAL EUROPE AND SPINNIN’ RECORDS LAUNCHES SPINNIN’ RECORDS GERMANY Further company coverage: WMG.O
04-10 17:06
BRIEF-FDA Approves New High Dose Regimen Of Spinraza® (Nusinersen) For Spinal Muscular Atrophy
BRIEF-FDA Approves New High Dose Regimen Of Spinraza® (Nusinersen) For Spinal Muscular Atrophy March 30 (Reuters) - Biogen Inc BIIB.O : FDA APPROVES NEW HIGH DOSE REGIMEN OF SPINRAZA® (NUSINERSEN) FOR SPINAL MUSCULAR ATROPHY BIOGEN - HIGH DOSE SPINRAZA TO BE AVAILABLE IN U.S. IN COMING WEEKS Source
03-30 20:01
BRIEF-Anaptys Announces $100 Million Stock Repurchase Plan And Provides A Business Update
BRIEF-Anaptys Announces $100 Million Stock Repurchase Plan And Provides A Business Update AnaptysBio Inc ANAB.O : ANAPTYS ANNOUNCES $100 MILLION STOCK REPURCHASE PLAN AND PROVIDES A BUSINESS UPDATE ANAPTYSBIO INC - TO SPIN-OFF BIOPHARMA OPERATIONS INTO FIRST TRACKS BIOTHERAPEUTICS ON APRIL 20, 2026
03-27 21:04
BRIEF-Anaptys Board Of Directors Approves Spin-Off Of First Tracks Biotherapeutics
BRIEF-Anaptys Board Of Directors Approves Spin-Off Of First Tracks Biotherapeutics AnaptysBio Inc ANAB.O : ANAPTYS BOARD OF DIRECTORS APPROVES SPIN-OFF OF FIRST TRACKS BIOTHERAPEUTICS Source text: ID:nGNX4WVKfC Further company coverage: ANAB.O
03-27 21:03
BRIEF-First Tracks Biotherapeutics, The Planned Spin-Off Of Anaptys, Secures Commitments Of $145 Million In Private Placement
BRIEF-First Tracks Biotherapeutics, The Planned Spin-Off Of Anaptys, Secures Commitments Of $145 Million In Private Placement AnaptysBio Inc ANAB.O : FIRST TRACKS BIOTHERAPEUTICS, THE PLANNED SPIN-OFF OF ANAPTYS, SECURES COMMITMENTS OF $145 MILLION IN PRIVATE PLACEMENT Source text: ID:nGNX1Ml9sl Fur
03-27 21:03
